Literature DB >> 2323315

Concurrent and simultaneous use of alcohol with cocaine: results of national survey.

B F Grant1, T C Harford.   

Abstract

The purpose of the present study was to determine the prevalence of the concurrent and simultaneous use of alcohol and cocaine in the general population and to examine differences in these rates between important sociodemographic subgroups. The results indicated that a sizable proportion of Americans were engaged in both substance use patterns. The population estimate for simultaneous use of both substances (i.e., simultaneously or on the same occasion) was approximately 4 million for the month preceding the interview, rising to approximately 9 million when the past year timeframe was considered. Corresponding figures for the concurrent use of alcohol and cocaine (i.e., use of both substances during the same time period) were approximately 5 million during the past month and 12 million during the past year. The extent of each substance use practice varied as a function of sociodemographic factors. Implications of these findings are discussed in terms of the need for age-sex-ethnic-specific prevention strategies. The need for future analytic epidemiologic research to determine the precise relationship between dose, frequency and duration of concurrent and simultaneous use and each adverse consequence is emphasized. The need for longitudinal research in the general population is also highlighted.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323315     DOI: 10.1016/0376-8716(90)90147-7

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  46 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Effects of cocaine and alcohol, alone and in combination, on human learning and performance.

Authors:  S T Higgins; C R Rush; J R Hughes; W K Bickel; M Lynn; M A Capeless
Journal:  J Exp Anal Behav       Date:  1992-07       Impact factor: 2.468

3.  Reduced posterior mesofrontal cortex activation by risky rewards in substance-dependent patients.

Authors:  James M Bjork; Reza Momenan; Ashley R Smith; Daniel W Hommer
Journal:  Drug Alcohol Depend       Date:  2008-03-04       Impact factor: 4.492

4.  Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration.

Authors:  M Pecins-Thompson; J Peris
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men.

Authors:  George Fein; Victoria Di Sclafani; Dieter J Meyerhoff
Journal:  Drug Alcohol Depend       Date:  2002-09-01       Impact factor: 4.492

6.  Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene.

Authors:  E F McCance-Katz; L H Price; C J McDougle; T R Kosten; J E Black; P I Jatlow
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Acute behavioral and cardiac effects of cocaine and alcohol combinations in humans.

Authors:  S T Higgins; C R Rush; W K Bickel; J R Hughes; M Lynn; M A Capeless
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Ethanol consumption reduces the adverse consequences of self-administered intravenous cocaine in rats.

Authors:  L A Knackstedt; A Ettenberg
Journal:  Psychopharmacology (Berl)       Date:  2004-08-25       Impact factor: 4.530

9.  Stimulant use, religiosity, and the odds of developing or maintaining an alcohol use disorder over time.

Authors:  Tyrone F Borders; Brenda M Booth
Journal:  J Stud Alcohol Drugs       Date:  2013-05       Impact factor: 2.582

10.  Polydrug use among club-going young adults recruited through time-space sampling.

Authors:  Christian Grov; Brian C Kelly; Jeffrey T Parsons
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.